Skip to main content
NIH funding notice RFA-OD-24-004

Federated Biobanking resource for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U24 Clinical Trial Not Allowed)

Closed on December 15, 2023.

Posted
October 19, 2023
Close date
December 15, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,110,455 in first-year total cost, median $5,110,455.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 IVBH-N (55)]1

Most frequent institutions

  1. UNIVERSITY OF COLORADO DENVER1
Competing awards under RFA-OD-24-004 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024The INCLUDE Project Down Syndrome Biorepository (DS-Biorepository)1U24AG092191-01ESPINOSA, JOAQUIN M.GALBRAITH, MATTHEW DHEAD, ELIZABETHRACHUBINSKI, ANGELA LYNNUNIVERSITY OF COLORADO DENVER, CO$5,110,455ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-OD-24-004: Federated Biobanking resource for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U24 Clinical Trial Not Allowed) | ScienceDex | ConductScience